Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) Reduces -29.88% In A Week: What’s Lifting The Stock?
In recent trading session, Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) saw 2.05 million shares changing hands at last check today with its beta currently measuring 0.42. Company’s